Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Timo Joensuu"'
Autor:
Matti Kankainen, Timo Joensuu, Akseli Hemminki, Juuso Juhila, Siri Tähtinen, Otto Hemminki, Anna Kanerva, Kristian Taipale, Ilkka Liikanen, Minna Oksanen, Dafne C A Quixabeira, Saru Basnet
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/8f3b74fc93134e3ea38d7aca73c18d0b
Autor:
Kalevi Kairemo, Aki Kangasmäki, Srinivasan Cheenu Kappadath, Timo Joensuu, Homer A. Macapinlac
Publikováno v:
Life, Vol 12, Iss 12, p 1977 (2022)
Bone is the most common metastatic site in prostate cancer (PCa). 68Ga-PSMA-11 (or gozetotide) and sodium fluoride-18 (Na18F) are rather new radiopharmaceuticals for assessing PCa-associated bone metastases. Gozetotide uptake reflects cell membrane e
Externí odkaz:
https://doaj.org/article/3eafddf3b63b48b092963ed4480fc293
Autor:
Otto Hemminki, Minna Oksanen, Kristian Taipale, Ilkka Liikanen, Anniina Koski, Timo Joensuu, Anna Kanerva, Akseli Hemminki
Publikováno v:
Molecular Therapy: Oncolytics, Vol 9, Iss , Pp 41-50 (2018)
The first US Food and Drug Administration (FDA)- and EMA-approved oncolytic virus has been available since 2015. However, there are no markers available that would predict benefit for the individual patient. During 2007–2012, we treated 290 patient
Externí odkaz:
https://doaj.org/article/f1ee0f5650ed47c7a5c0668c663a704c
Publikováno v:
Diagnostics, Vol 11, Iss 1, p 17 (2020)
Bone metastases are common in prostate cancer (PCa). Fluorocholine-18 (FCH) and sodium fluoride-18 (NaF) have been used to assess PCa associated skeletal disease in thousands of patients by demonstrating different mechanism of uptake-cell membrane (l
Externí odkaz:
https://doaj.org/article/cf7c5e90da264385a3c074e438827b71
Autor:
Timo Kiljunen, Saad Akram, Jarkko Niemelä, Eliisa Löyttyniemi, Jan Seppälä, Janne Heikkilä, Kristiina Vuolukka, Okko-Sakari Kääriäinen, Vesa-Pekka Heikkilä, Kaisa Lehtiö, Juha Nikkinen, Eduard Gershkevitsh, Anni Borkvel, Merve Adamson, Daniil Zolotuhhin, Kati Kolk, Eric Pei Ping Pang, Jeffrey Kit Loong Tuan, Zubin Master, Melvin Lee Kiang Chua, Timo Joensuu, Juha Kononen, Mikko Myllykangas, Maigo Riener, Miia Mokka, Jani Keyriläinen
Publikováno v:
Diagnostics, Vol 10, Iss 11, p 959 (2020)
A commercial deep learning (DL)-based automated segmentation tool (AST) for computed tomography (CT) is evaluated for accuracy and efficiency gain within prostate cancer patients. Thirty patients from six clinics were reviewed with manual- (MC), auto
Externí odkaz:
https://doaj.org/article/c158ba65598c429d89057b3a14adce51
Autor:
Kalevi Kairemo, Timo Joensuu
Publikováno v:
Diagnostics, Vol 5, Iss 4, Pp 413-427 (2015)
The purpose of this study was to evaluate the outcome after Radium-223-dichloride (223RaCl2) treatment of patients with skeletal metastases of castration resistant prostate cancer using whole-body 18F-Fluoride PET/CT. Sodium 18F-fluoride [18F]-NaF PE
Externí odkaz:
https://doaj.org/article/349dbf300fa54185ac65043dcba9ad4d
Publikováno v:
Diagnostics, Vol 5, Iss 3, Pp 358-368 (2015)
Radium-223-dichloride (223RaCl2) is a new bone-seeking calcium analogue alpha-emitter, which has obtained marketing authorization for the treatment skeletal metastases of hormone-refractory prostate cancer. The current treatment regimen is based on s
Externí odkaz:
https://doaj.org/article/9a1fce6d366a4634862cd13efeb290a0
Autor:
Akseli Hemminki, Lotta Kangasniemi, Sari Pesonen, Kalevi Kairemo, Leena Laasonen, Kaarina Partanen, Tuomo Alanko, Timo Joensuu, Saila Pesonen, Raita Heiskanen, Minna Oksanen, Siri Tähtinen, Ilkka Liikanen, Vincenzo Cerullo, Anniina Koski, Iulia Diaconu, Petri Nokisalmi, Anna Kanerva
PDF file - 100K, PBMCs were isolated from patients before and circa one month after treatment and pulsed with an adenovirus-derived peptide pool and analyzed with IFN-gamma ELISPOT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d9a12bcec8d4b1d859164f3d0d4004
https://doi.org/10.1158/1078-0432.22446975
https://doi.org/10.1158/1078-0432.22446975
Autor:
Akseli Hemminki, Lotta Kangasniemi, Sari Pesonen, Kalevi Kairemo, Leena Laasonen, Kaarina Partanen, Tuomo Alanko, Timo Joensuu, Saila Pesonen, Raita Heiskanen, Minna Oksanen, Siri Tähtinen, Ilkka Liikanen, Vincenzo Cerullo, Anniina Koski, Iulia Diaconu, Petri Nokisalmi, Anna Kanerva
Purpose: Multiple injections of oncolytic adenovirus could enhance immunologic response. In the first part of this article, the focus was on immunologic aspects. Sixty patients previously naïve to oncolytic virus and who had white blood cells availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369f9b8d7f48d80f09a3e4740a74a9d0
https://doi.org/10.1158/1078-0432.c.6520932
https://doi.org/10.1158/1078-0432.c.6520932
Autor:
Akseli Hemminki, Lotta Kangasniemi, Sari Pesonen, Kalevi Kairemo, Leena Laasonen, Kaarina Partanen, Tuomo Alanko, Timo Joensuu, Saila Pesonen, Raita Heiskanen, Minna Oksanen, Siri Tähtinen, Ilkka Liikanen, Vincenzo Cerullo, Anniina Koski, Iulia Diaconu, Petri Nokisalmi, Anna Kanerva
PDF file - 62K, Adverse reactions of all CGTG-102 patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f3c7a7a9419f92f10d112fb18c460e
https://doi.org/10.1158/1078-0432.22446954
https://doi.org/10.1158/1078-0432.22446954